Study on the Reduction of Tumor Cell Burden With Bortezomib (Vel), Cyclophosphamide (C) and Dexamethasone (D) Before Stem Cell Transplantation (So-called Induction Therapy) in Patients With Multiple Myeloma Aged 60 Years or Less.
This study has been completed.
Information provided by:
First received: January 23, 2009
Last updated: July 15, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2009|
|Primary Completion Date:||June 2009 (Final data collection date for primary outcome measure)|